Back to Search
GEORGE SOMLO, MD
MD
Hematology & Oncology Physician
NPI: 1831206861Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A40179(CA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A40179(CA)
Research & Publications (20)
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome.
PMID 18641005·Ann Oncol·2008
8-other
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
PMID 15143076·J Clin Oncol·2004
8-other
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer.
PMID 12177795·Br J Cancer·2002
8-other
Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies.
PMID 11400951·Biol Blood Marrow Transplant·2001
3-trial
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
PMID 11401310·Br J Cancer·2001
3-trial
Breast cancer. Clinical practice guidelines in oncology.
PMID 19200416·J Natl Compr Canc Netw·2009
6-review
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.
PMID 19322566·Cancer Chemother Pharmacol·2009
3-trial
Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
PMID 19661346·Anticancer Res·2009
3-trial
Bortezomib therapeutic effect is associated with expression of FGFR3 in multiple myeloma cells.
PMID 19331127·Anticancer Res·2009
8-other
Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.
PMID 19443352·Anticancer Res·2009
3-trial
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation.
PMID 19564171·Ann Oncol·2009
8-other
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
PMID 19307510·J Clin Oncol·2009
3-trial
Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation.
PMID 18786784·Int J Radiat Oncol Biol Phys·2009
3-trial
Association of reactive oxygen species levels and radioresistance in cancer stem cells.
PMID 19194462·Nature·2009
7-preclinical
Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
PMID 19535777·J Natl Cancer Inst·2009
8-other
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
PMID 19665978·Cell·2009
8-other
An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature.
PMID 18500673·Breast Cancer Res Treat·2009
6-review
Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia.
PMID 18497517·Onkologie·2008
5-case
A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.
PMID 18981013·Clin Cancer Res·2008
3-trial
Second malignancies after allogeneic hematopoietic cell transplantation.
PMID 17889348·Biol Blood Marrow Transplant·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1500 E DUARTE RD
DUARTE, CA 91010 - Phone
- (626) 359-8111
Quick Facts
- NPI
- 1831206861
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile